A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin

Biochemical Pharmacology

Volumn 57, Issue 11, 1999, Pages 1265-1273

  Chan, Pui K ^a   Chan, Fung Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Daunomycin; NPM translocation; Nucleophosmin; Tumor cells

Indexed keywords

DAUNORUBICIN; DNA FRAGMENT; NUCLEOPHOSMIN;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL DIVISION; DAUNORUBICIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; K562 CELLS; NUCLEAR PROTEINS;

EID: 0033151518     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00043-X     Document Type: Article

References (43)

1. Busch H., Smetana K. Introduction. The Nucleolus. 1970;1-49 Academic Press, New York.
2. Hadjiolov AA, The Nucleolus and Ribosome Biogenesis. 1985;Springer, New York.
3. Warner J.R. Synthesis of ribosomes in Saccharomyces cerevisiae. Microbiol Rev. 53:1989;256-271.
4. Schneiter R., Kadowaki T., Tartakoff A.M. mRNA transport in yeast Time to reinvestigate the functions of the nucleolus . Mol Biol Cell. 6:1995;357-370.
5. Fankhauser C., Izaurralde E., Adache Y., Wingfield P., Laemmli U.K. Specific complex of human immunodeficiency virus type 1 Rev and nucleolar B23 proteins Dissociation by the Rev response element . Mol Cell Biol. 11:1991;2567-2575.
6. Marasco W.A., Szilvay A.M., Kalland K.H., Helland D.G., Reyes H.M., Walter R.J. Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arch Virol. 139:1994;133-154.
7. Snyder A.L., Kann H.E. Jr, Kohn K.W. Inhibition of the processing of ribosomal precursor RNA by intercalating agents. J Mol Biol. 58:1971;555-565.
8. R and the newer anthracyclines, carminomycin and marcellomycin. Cancer Res. 38:1978;467-473.
9. Kapuscinski J., Darzynkiewcz Z. Relationship between the pharmacological activity of antitumor drugs ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids. Proc Natl Acad Sci USA. 83:1986;6302-6306.
10. Farabegoli F., Govoni M., Novello F. Effects of camptothecin, an inhibitor of DNA topoisomerase I on ribosomal gene structure and function in TG cells. Biol Cell. 74:1992;281-286.
11. Chan W.Y., Liu Q.R., Borjigin J., Busch H., Rennert O.R., Tease L.A., Chan P.K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry. 28:1989;1033-1039.
12. Schmidt-Zachmann M.S., Hugle-Dorr B., Franke W.W. A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J. 6:1987;1881-1890.
13. Feuerstein N., Mond J.J. "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem. 262:1987;11389-11397.
14. Chan P.K., Chan F.Y., Morris S.W., Xie Z. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene Identification of the YY1 binding site at the 5′ enhancer region . Nucleic Acids Res. 25:1997;1225-1232.
15. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 263:1994;1281-1284.
16. Redner R.L., Ruch E.A., Faas S., Rudert W.A., Corey S.J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood. 87:1996;882-886.
17. Sandlund J.T., Downing J.R., Crist W.M. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 334:1996;1238-1248.
18. Liu Q.R., Chan P.K. Formation of nucleophosmin/B23 oligomers requires both the amino and the carboxyl-terminal domains of the protein. Eur J Biochem. 200:1991;715-721.
19. Borer R.A., Lehner C.F., Eppenberger H.M., Nigg E.A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 60:1989;379-390.
20. Inouye C.J., Seto E. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem. 269:1994;6506-6510.
21. Valdez B.C., Perlaky L., Henning D., Saijo Y., Chan P.K., Busch H. Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem. 269:1994;23776-23783.
22. Perlaky L., Valdez B.C., Busch H. Effect of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu. Exp Cell Res. 235:1997;413-420.
23. Finch R.A., Revankar G.R., Chan P.K. Nucleolar localization of nucleophosmin/B23 requires GTP. J Biol Chem. 268:1993;5823-5827.
24. Finch R.A., Chang D., Chan P.K. GTP S restores nucleophosmin (NPM) localization to nucleoli of GTP-depleted HeLa cells. Mol Cell Biochem. 146:1995;171-178.
25. Wu M.H., Lan C.Y., Yung B.Y.M. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. Biochem J. 305:1995;987-992.
26. Finch R.A., Chan P.K. ATP depletion affects NPM translocation and exportation of rRNA from nuclei. Biochem Biophys Res Commun. 222:1996;553-558.
27. Yung B.Y.M., Busch R.K., Busch H., Mauger A.B., Chan P.K. Effects of actinomycin D analogs on nucleolar phosphoproteins B23 (37 kD/pI 5.1). Biochem Pharmacol. 34:1985;4059-4063.
28. Chan P.K., Aldrich M.B., Yung B.Y.M. Studies of nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells. Cancer Res. 47:1987;3798-3801.
29. Sweet P., Chan P.K., Slater L.M. Cyclosporin A and Verapamil enhancement of daunorubicin-produced nucleolar protein b23 translocation in daunorubicin-resistant and -sensitive tumor cells. Cancer Res. 49:1989;677-680.
30. Yung B.Y.M., Bor M.S., Chan P.K. Short exposure of actinomycin D induced "reversible" translocation of protein B23, inhibition of cell growth and RNA synthesis. Cancer Res. 50:1990;5987-5991.
31. Chan P.K. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Exp Cell Res. 203:1992;174-181.
32. Chan P.K., Qi Y., Amley J., Koller C.A. Quantitation of the NPM-translocation using imaging analysis. Cancer Lett. 100:1996;191-197.
33. Giloh H., Sedat J.W. Fluorescence microscopy: Reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl-gallate. Science. 217:1982;1252-1255.
34. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay Assessment of chemosensitivity testing . Cancer Res. 47:1987;936-942.
35. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
36. Skladanowski A., Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem Pharmacol. 46:1993;375-382.
37. Thompson B.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
38. Yung B.Y.M., Chan P.K. Identification and characterization of a hexameric form of nucleolar phosphoprotein B23. Biochim Biophys Acta. 925:1987;74-82.
39. Gottlieb T.M., Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta. 1287:1996;77-102.
40. Danks M.K., Garrett K.E., Marion R.C., Whipple D.O. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan. Cancer Res. 56:1996;1664-1673.
41. Buckwalter C.A., Li A.H., Tanizawa A., Pommier Y.G., Cheng Y.C., Kaufmann H. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Cancer Res. 56:1996;1674-1681.
42. Kill I.R. Localisation of the Ki-67 antigen within the nucleolus. J Cell Sci. 109:1996;1253-1263.
43. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.